|
31 Jul 2025 |
Vinati Organics
|
Consensus Share Price Target
|
1831.60 |
2090.67 |
- |
14.14 |
buy
|
|
|
|
|
03 Jul 2025
|
Vinati Organics
|
Sharekhan
|
1831.60
|
2300.00
|
1960.10
(-6.56%)
|
25.57 |
Buy
|
|
|
Vinati Organics delivered a robust FY25, with an 18.3% year-on-year revenue increase, a 23.7% rise in operating profit, and a 25.8% surge in net profit. Growth was primarily driven by ATBS and Antioxidants.
|
|
28 May 2025
|
Vinati Organics
|
Sharekhan
|
1831.60
|
2100.00
|
1816.30
(0.84%)
|
14.65 |
Buy
|
|
|
Vinati Organics reported a strong Q4FY25 with revenue up 17.5% y-o-y, operating profit growth of 20.4% and net profit increase of 18.1% y-o-y.
|
|
17 May 2025
|
Vinati Organics
|
Motilal Oswal
|
1831.60
|
2195.00
|
1778.20
(3.00%)
|
19.84 |
Buy
|
|
|
Vinati Organics (VO)’s 4QFY25 revenue came in line at INR6.5b. Gross margin expanded 80bp YoY to 47.4%, while EBITDAM was up 100bp YoY at 28.3%. EBITDA increased 22% YoY to INR1.8b and PAT grew 22% to INR1.3b (our est. INR1.2b). All the key segments reported strong growth in FY25.
|
|
16 May 2025
|
Vinati Organics
|
Prabhudas Lilladhar
|
1831.60
|
1882.00
|
1778.20
(3.00%)
|
Target met |
Accumulate
|
|
|
Vinati Organics (VO IN) reported revenue of Rs6.5bn in Q4FY25, marking a robust 17.8% YoY and 24% sequential increase. The management has reiterated its guidance of 20% revenue CAGR over the next 3 years, along with EBITDA margins in the range of 26%27%. ATBS, the company's key highmargin product, delivered strong growth during the quarter, driven by rising demand in the O&G sector, where it is used as a tertiary oil recovery agent. The antioxidants segment, which generated ~Rs2.2bn revenue in FY25, is expected to see robust growth ahead, supported by annual contracts the company plans to secure with domestic customers. New products like MEHQ and Guaiacol are...
|
|
19 Mar 2025
|
Vinati Organics
|
Sharekhan
|
1831.60
|
2000.00
|
1599.40
(14.52%)
|
Target met |
Buy
|
|
|
Vinati Organics is expanding its ATBS capacity to 60,000 MT by Q1FY26, driven by strong demand and a favorable outlook for the US oil & gas sector.
|
|
05 Feb 2025
|
Vinati Organics
|
Edelweiss
|
1831.60
|
2250.00
|
1771.35
(3.40%)
|
22.84 |
Buy
|
|
|
Volume growth seen; healthy growth to continue
|
|
03 Feb 2025
|
Vinati Organics
|
Motilal Oswal
|
1831.60
|
2600.00
|
1746.50
(4.87%)
|
41.95 |
Buy
|
|
|
Vinati Organics (VO)’s 3QFY25 revenue came in a tad above our estimate at INR5.2b. Gross margin expanded 180bp YoY to 49%, while EBITDAM was up 180bp YoY at 27.4%. EBITDA increased 24% YoY to INR1.4b and PAT grew 24% to INR956m (our est. INR1b).
|
|
30 Oct 2024
|
Vinati Organics
|
CD Equisearch
|
1831.60
|
1886.00
|
1934.90
(-5.34%)
|
Target met |
Hold
|
|
|
|
|
16 Oct 2024
|
Vinati Organics
|
Motilal Oswal
|
1831.60
|
2500.00
|
2005.00
(-8.65%)
|
36.49 |
Buy
|
|
|
Vinati Organics (VO) has strengthened its operations through backward integration, which is expected to expand its margins.
|
|
19 Aug 2024
|
Vinati Organics
|
Sharekhan
|
1831.60
|
2243.00
|
2016.60
(-9.17%)
|
22.46 |
Hold
|
|
|
Q1 PAT of Rs. 86 crore, which is an 18% decline q-o-q, fell 22% short of our estimate due to weaker-than-expected revenue and higher raw material costs.
|
|
12 Aug 2024
|
Vinati Organics
|
Prabhudas Lilladhar
|
1831.60
|
2237.00
|
2107.60
(-13.10%)
|
22.13 |
Accumulate
|
|
|
|
|
12 Aug 2024
|
Vinati Organics
|
Motilal Oswal
|
1831.60
|
2425.00
|
2107.60
(-13.10%)
|
32.40 |
Buy
|
|
|
Vinati Organics (VO)’s 1QFY25 revenue came in below our estimate at INR5.2b. Gross margin declined 270bp YoY to 44.9%, while EBITDAM was up 100bp YoY at 23.8%.
|
|
20 May 2024
|
Vinati Organics
|
Edelweiss
|
1831.60
|
1934.00
|
1667.20
(9.86%)
|
Target met |
Buy
|
|
|
Sequential recovery in Q4; a healthy growth to sustain
|
|
19 May 2024
|
Vinati Organics
|
Motilal Oswal
|
1831.60
|
2080.00
|
1667.20
(9.86%)
|
Target met |
Buy
|
|
|
Vinati Organics (VO)’s revenue came above our estimate due to a robust recovery in volumes across products in 4QFY24. However, gross margin contracted 310bp YoY to 46.6%, while EBITDAM was down 110bp YoY to 27.3%. EBITDA rose 2% YoY to INR1.5b, while PAT was flat at INR1b (our est. INR630m).
|
|
14 Mar 2024
|
Vinati Organics
|
Geojit BNP Paribas
|
1831.60
|
1844.00
|
1592.85
(14.99%)
|
Target met |
Accumulate
|
|
|
|
|
05 Mar 2024
|
Vinati Organics
|
Prabhudas Lilladhar
|
1831.60
|
1626.00
|
1629.65
(12.39%)
|
Target met |
Hold
|
|
|
|
|
10 Nov 2023
|
Vinati Organics
|
Prabhudas Lilladhar
|
1831.60
|
1997.00
|
1754.35
(4.40%)
|
Target met |
Accumulate
|
|
|
|
|
06 Nov 2023
|
Vinati Organics
|
CD Equisearch
|
1831.60
|
1829.00
|
1752.85
(4.49%)
|
Target met |
Hold
|
|
|
|
|
30 Aug 2023
|
Vinati Organics
|
Motilal Oswal
|
1831.60
|
2150.00
|
1846.50
(-0.81%)
|
Target met |
Buy
|
|
|
|
|
17 Aug 2023
|
Vinati Organics
|
Edelweiss
|
1831.60
|
1934.00
|
1813.75
(0.98%)
|
Target met |
Buy
|
|
|
Weak performance owing to subdued demand for ATBS
|